Trellus Health plc
TRLHF
$0.015
$0.000.00%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | 150.00% | 85.00% | 5.56% | -22.64% | -37.14% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 150.00% | 85.00% | 5.56% | -22.64% | -37.14% |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 150.00% | 85.00% | 5.56% | -22.64% | -37.14% |
SG&A Expenses | -12.03% | -20.54% | -27.91% | -25.23% | -22.84% |
Depreciation & Amortization | 29.10% | 29.10% | 29.10% | 116.20% | 1,575.00% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -9.14% | -17.28% | -24.40% | -20.74% | -17.29% |
Operating Income | 9.60% | 17.53% | 24.46% | 20.74% | 17.21% |
Income Before Tax | 11.60% | 20.46% | 28.05% | 22.85% | 17.85% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 11.60% | 20.46% | 28.05% | 22.85% | 17.85% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 11.60% | 20.46% | 28.05% | 22.85% | 17.85% |
EBIT | 9.60% | 17.53% | 24.46% | 20.74% | 17.21% |
EBITDA | 9.29% | 17.45% | 24.55% | 20.91% | 18.10% |
EPS Basic | 11.59% | 20.55% | 28.21% | 23.39% | 18.82% |
Normalized Basic EPS | 13.29% | 22.19% | 29.76% | 25.00% | 20.56% |
EPS Diluted | 11.59% | 20.55% | 28.21% | 23.39% | 18.82% |
Normalized Diluted EPS | 13.29% | 22.19% | 29.76% | 25.00% | 20.56% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.49% | 0.99% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.49% | 0.99% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |